The GTF2A1L gene is cancer-significant, and there are materials on the relationship of its expression with such oncological diseases as breast angiosarcoma [79], endometrial carcinoma [80], bladder cancer [81], and medulloblastoma in children [82]. This evidence concerns the gene GTF2A1L and medulloblastoma.